PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brheartjLink to Publisher's site
 
Br Heart J. 1992 December; 68(6): 537–539.
PMCID: PMC1025679

Viable myocardium and reinjection of thallium

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (642K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation. 1975 Apr;51(4):641–645. [PubMed]
  • Kotler TS, Diamond GA. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med. 1990 Nov 1;113(9):684–702. [PubMed]
  • Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation. 1991 Feb;83(2):363–381. [PubMed]
  • DePasquale EE, Nody AC, DePuey EG, Garcia EV, Pilcher G, Bredlau C, Roubin G, Gober A, Gruentzig A, D'Amato P, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation. 1988 Feb;77(2):316–327. [PubMed]
  • Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983 Aug;68(2):321–336. [PubMed]
  • Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986 Mar;7(3):464–471. [PubMed]
  • Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, Pohost GM. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol. 1983 Apr;1(4):994–1001. [PubMed]
  • Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol. 1988 Jul;12(1):25–34. [PubMed]
  • Kaul S, Lilly DR, Gascho JA, Watson DD, Gibson RS, Oliner CA, Ryan JM, Beller GA. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation. 1988 Apr;77(4):745–758. [PubMed]
  • Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation. 1977 Feb;55(2):294–302. [PubMed]
  • Blood DK, McCarthy DM, Sciacca RR, Cannon PJ. Comparison of single-dose and double-dose thallium-201 myocardial perfusion scintigraphy for the detection of coronary artery disease and prior myocardial infarction. Circulation. 1978 Nov;58(5):777–788. [PubMed]
  • Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986 Apr 3;314(14):884–888. [PubMed]
  • Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol. 1986 Dec;8(6):1467–1470. [PubMed]
  • Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol. 1987 Sep;10(3):557–567. [PubMed]
  • Bulkley BH, Silverman K, Weisfeldt ML, Burow R, Pond M, Becker LC. Pathologic basis of thallium-201 scintigraphic defects in patients with fatal myocardial injury. Circulation. 1979 Oct;60(4):785–792. [PubMed]
  • Liu P, Kiess MC, Okada RD, Block PC, Strauss HW, Pohost GM, Boucher CA. The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? Am Heart J. 1985 Nov;110(5):996–1001. [PubMed]
  • Gibson RS, Watson DD, Taylor GJ, Crosby IK, Wellons HL, Holt ND, Beller GA. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol. 1983 Mar;1(3):804–815. [PubMed]
  • Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med. 1992 Apr;33(4):505–511. [PubMed]
  • Gewirtz H, Beller GA, Strauss HW, Dinsmore RE, Zir LM, McKusick KA, Pohost GM. Transient defects of resting thallium scans in patients with coronary artery disease. Circulation. 1979 Apr;59(4):707–713. [PubMed]
  • Berger BC, Watson DD, Burwell LR, Crosby IK, Wellons HA, Teates CD, Beller GA. Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation. 1979 Nov;60(5):1114–1125. [PubMed]
  • Ritchie JL, Albro PC, Caldwell JH, Trobaugh GB, Hamilton GW. Thallium-201 myocardial imaging: a comparison of the redistribution and rest images. J Nucl Med. 1979 Jun;20(6):477–483. [PubMed]
  • Kiat H, Berman DS, Maddahi J, De Yang L, Van Train K, Rozanski A, Friedman J. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988 Dec;12(6):1456–1463. [PubMed]
  • Gutman J, Berman DS, Freeman M, Rozanski A, Maddahi J, Waxman A, Swan HJ. Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis. Am Heart J. 1983 Nov;106(5 Pt 1):989–995. [PubMed]
  • Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med. 1990 Oct;31(10):1617–1623. [PubMed]
  • Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990 Jul 19;323(3):141–146. [PubMed]
  • Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol. 1990 Aug 15;66(4):394–399. [PubMed]
  • Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol. 1990 Jul 15;66(2):158–163. [PubMed]
  • Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med. 1991 Sep;32(9):1718–1724. [PubMed]
  • Dilsizian V, Smeltzer WR, Freedman NM, Dextras R, Bonow RO. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium? Circulation. 1991 Apr;83(4):1247–1255. [PubMed]
  • Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation. 1991 Jan;83(1):26–37. [PubMed]
  • Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med. 1991 Apr;32(4):673–678. [PubMed]
  • Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990 Apr;15(5):1021–1031. [PubMed]
  • Pennell DJ, Underwood SR, Manzara CC, Swanton RH, Walker JM, Ell PJ, Longmore DB. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992 Jul 1;70(1):34–40. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Group